USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name: AVIRON
City: MOUNTAIN VIEW
State: CA
Zip+4: 94043
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
Website URL: N/A
Phone: (650) 919-6553

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $806,137.00 9
SBIR Phase II $2,434,867.00 4

Award List:

Improved Influenza a and B Virus Vaccines

Award Year / Program / Phase: 1995 / SBIR / Phase I
Agency: HHS
Principal Investigator: Shengqiang Li
Award Amount: $75,000.00
Abstract:
Improved replication of vaccine seed strains in embryonated hens' eggs would lower the cost of manuinactivated influenza vaccines and allow more doses to be manufactured. Higher-growing influenza A aviruses will be developed that can be genetically reasserted with poorly-growing fresh human… More

DEVELOPMENT OF RATIONALLY DESIGNED HCMV VACCINE STRAINS

Award Year / Program / Phase: 1997 / SBIR / Phase I
Agency: HHS
Principal Investigator: Kemble, george w
Award Amount: $99,537.00

RATIONAL DESIGN OF A LIVE, ATTENUATED HSV2 VACCINE

Award Year / Program / Phase: 1998 / SBIR / Phase I
Agency: HHS
Principal Investigator: Kemble, George W
Award Amount: $99,737.00

Clinical Trials of a Genetically Engineered HCMV

Award Year / Program / Phase: 1998 / SBIR / Phase II
Agency: HHS
Principal Investigator: Kemble, george w
Award Amount: $753,388.00

MUCOSAL IMMUNITY & REPLICATION OF HUMAN CYTOMEGALOVIRUS

Award Year / Program / Phase: 1999 / SBIR / Phase I
Agency: HHS
Principal Investigator: George W. Kemble
Award Amount: $332,942.00
Abstract:
Not Available Faster and more efficient methods are needed for developing scenario-based team and individual performance measures for distributed simulation environments. Aptima proposes a steamlined approach to identify critical team competencies, knowledge, and skills. This approach combines… More

BOVINE PARAINFLUENZA 3 VIRUS AS A NOVEL VACCINE VECTOR

Award Year / Program / Phase: 1999 / SBIR / Phase I
Agency: HHS
Principal Investigator: Aurelia A. Haller
Award Amount: $99,784.00
Abstract:
Not Available Q-Peak, Inc. proposes to develop a broadly tunable, l0-W-average-power IR source suitable for use as a DIAL system transmitter and based on the combination of a Nd-doped pulsed pump laser and optical parametric oscillators (OPO) The laser source, a compact, diode-pumped, 5-10 kHz… More

CHIMERIC RSV SUBGROUP A AND B VACCINE CANDIDATES

Award Year / Program / Phase: 1999 / SBIR / Phase I
Agency: HHS
Principal Investigator: Hong Jin
Award Amount: $99,137.00
Abstract:
Not Available Physical Sciences Inc., Thiokol Propulsion, and Lockheed Martin Missile and Space propose to develop spacecraft structural materials which can withstand mechanical loads during launch and can be consumed as propellants for on-orbit propulsion. Spacecraft structural elements… More

N/A

Award Year / Program / Phase: 2000 / SBIR / Phase I
Agency: HHS
Principal Investigator: Hong Jin
Award Amount: $0.00

N/A

Award Year / Program / Phase: 2000 / SBIR / Phase II
Agency: HHS
Principal Investigator: Hong Jin
Award Amount: $653,200.00

Generation of bPIV3-vectored PIV and RSV Vaccines

Award Year / Program / Phase: 2001 / SBIR / Phase I
Agency: HHS
Principal Investigator: Aurelia A. Haller
Award Amount: $0.00

Generation of bPIV3-vectored PIV and RSV Vaccines

Award Year / Program / Phase: 2001 / SBIR / Phase II
Agency: HHS
Principal Investigator: Aurelia A. Haller
Award Amount: $602,329.00

DEVELOPMENT OF A LIVE ATTENUATED HSV-2 VACCINE

Award Year / Program / Phase: 2001 / SBIR / Phase I
Agency: HHS
Principal Investigator: Mark N. Prichard
Award Amount: $0.00
Abstract:
DESCRIPTION: (Adapted from Applicant's Abstract) Genital herpes is a major health problem in the U.S. The prevalence of these infections is dramatically increasing despite effective antiviral drugs. This increase puts young adults and infants at risk of genital and neonatal… More

DEVELOPMENT OF A LIVE ATTENUATED HSV-2 VACCINE

Award Year / Program / Phase: 2001 / SBIR / Phase II
Agency: HHS
Principal Investigator: Mark N. Prichard
Award Amount: $425,950.00
Abstract:
DESCRIPTION: (Adapted from Applicant's Abstract) Genital herpes is a major health problem in the U.S. The prevalence of these infections is dramatically increasing despite effective antiviral drugs. This increase puts young adults and infants at risk of genital and neonatal… More